Lecture 13: Optimising drug properties to ensure good oral bioavailability

studied byStudied by 0 people
0.0(0)
learn
LearnA personalized and smart learning plan
exam
Practice TestTake a test on your terms and definitions
spaced repetition
Spaced RepetitionScientifically backed study method
heart puzzle
Matching GameHow quick can you match all your cards?
flashcards
FlashcardsStudy terms and definitions

1 / 31

encourage image

There's no tags or description

Looks like no one added any tags here yet for you.

32 Terms

1

what are the requirements of a good drug?

  • Efficacy o Must achieve the intended therapeutic effect.

  • Appropriate size and structure to interact with target.

  • Chemical stability.(over entire

  • Solubility

  • Drug needs to be in solution to be absorbed

  • Suitable LogP value (~1-3).

  • Oral bioavailability.

  • Appropriate pharmacokinetics.

  • Favourable safety profile.(not toxic, treating without lots of side effects)

New cards
2

A drug which is highly active in vitro is of no use of it can't be absorbed or if it has poor in vivo performance (e.g. extensive metabolism, toxicity).

New cards
3

recap of ficks first law of diffusion and how is it used?

  • Describes drug diffusion across a membrane.

  • Can also be applied to diffusion rate (flux) across a whole epithelium (considering A and h).

  • Properties of the drug are K, ΔC and radius (MW).

<ul><li><p>Describes drug diffusion across a membrane. </p></li><li><p>Can also be applied to diffusion rate (flux) across a whole epithelium (considering A and h). </p></li><li><p> Properties of the drug are K, ΔC and radius (MW).</p></li></ul><p></p>
New cards
4

what is the stokes einstein equation?

knowt flashcard image
New cards
5
  • We use the partition coefficient (P) of a drug between octanol and water as a substitute for K, the partition coefficient of drug into a biological membrane.

  • This is a measure of drug lipophilicity and is usually expressed as the log10 value, LogP.

  • Commonly determined using the "shake flask" method.

  • Can also be determined by dividing solubility in oil by solubility in water.

  • More modern methods include use of HPLC and, increasingly, in silico methods.

  • Values calculated by computer-based methods are known as cLogP.

HPLC compares the mobility of drugs and is much faster however can be less accurate

New cards
6

lipophilicity is the key physicochemical parameter in drug development

New cards
7

what happens if the drug is too hydrophilic?

•If a drug is too hydrophilic, its solubility will be good, but it will be poor at partitioning into the cell membrane.

<p>•If a drug is too hydrophilic, its solubility will be good, but it will be poor at partitioning into the cell membrane.</p>
New cards
8

what happens if the drug is too lipophilic?

  • A drug needs enough lipophilic character to partition into the cell membrane but not be too lipophilic.

  • If a drug's lipophilicity is too high, it's solubility will be poor, and it will struggle partition back out of the membrane - it may also accumulate in fatty tissues.

<ul><li><p>A drug needs enough lipophilic character to partition into the cell membrane but not be too lipophilic. </p></li><li><p>If a drug's lipophilicity is too high, it's solubility will be poor, and it will struggle partition back out of the membrane - it may also accumulate in fatty tissues.</p></li></ul><p></p>
New cards
9

what determines a drugs hydrophilicity or lipophilicity?

  • The chemical structure of a drug underpins its hydro- or lipophilicity.

  • For optimal absorption, drug needs a suitable balance of solubility & lipophilicity.

<ul><li><p>The chemical structure of a drug underpins its hydro- or lipophilicity. </p></li><li><p> For optimal absorption, drug needs a suitable balance of solubility &amp; lipophilicity.</p></li></ul><p></p>
New cards
10

what affects the lipophilicity and LogP of drugs?

  • A number of aspects of chemical structure affect the solubility and lipophilicity of drugs.

  • Among these are ionization and hydrogen bonding.

New cards
11

how does pH affect oral drug absorption?

  • Most small drugs are weak acids or bases - their ionization changes with varying pH according to their pKa.

  • Ionization affects the lipophilicity of drugs.

<ul><li><p>Most small drugs are weak acids or bases - their ionization changes with varying pH according to their pKa. </p></li><li><p> Ionization affects the lipophilicity of drugs.</p></li></ul><p></p>
New cards
12

how do ionised drugs affect hydro/lipophilicity?

•Ionized drugs: increased hydrophilicity vs. un-ionized form - reduced membrane permeability.

New cards
13

how do unionised drugs affect hydro/lipophilicity?

  • Un-ionized drugs: increased lipophilicity vs. ionized form

  • optimal membrane permeability.

New cards
14

how are strong acids/bases absorbed?

  • Strong acids (pKa < 3) and strong bases (pKa > 10) are poorly absorbed.

  • For an acid with pKa of 2 or a base with pKa of 11, only 0.003% of molecules are un-ionized at pH 6.5.

<ul><li><p>Strong acids (pKa &lt; 3) and strong bases (pKa &gt; 10) are poorly absorbed. </p></li><li><p> For an acid with pKa of 2 or a base with pKa of 11, only 0.003% of molecules are un-ionized at pH 6.5.</p></li></ul><p></p>
New cards
15

what is the pH partition hypothesis?

  • AH and B: Un-ionized drug = lipophilic optimal membrane transport

  • A- and BH+: Ionized drug = hydrophilic reduced membrane transport.

  • Drug accumulates on the side of the membrane where pH favours ionization. This is the pH partition hypothesis.

New cards
16

what does the pH partition hypothesis not take into account?

A useful concept but doesn't take into account:

  • Type of epithelium.

  • Surface area of the absorption site.

  • Ionized drugs will be absorbed to a small extent.

  • Active transport of drugs.

  • Residence time of drug at delivery site.

  • Charged drugs may form ion pairs with oppositely charged species.

<p>A useful concept but doesn't take into account: </p><ul><li><p>Type of epithelium. </p></li><li><p>Surface area of the absorption site. </p></li><li><p>Ionized drugs will be absorbed to a small extent. </p></li><li><p>Active transport of drugs. </p></li><li><p>Residence time of drug at delivery site. </p></li><li><p>Charged drugs may form ion pairs with oppositely charged species.</p></li></ul><p></p>
New cards
17

e.g 1: Based on the pH partition hypothesis, will the absorption of ibuprofen be highest in the fasted stomach (pH 2) or small intestine (pH 6.5)?

open notes

<p>open notes</p>
New cards
18

continuation to the example question(graph)

  • Ibuprofen is un-ionized, therefore more absorbable, in the fasted (empty) stomach - however, its solubility is poor.

  • Aspirin is un-ionized in the stomach and is more soluble so is absorbed there.

  • Many drugs are absorbed well in the stomach, but the adaptations of the small intestine mean most absorption occurs there.

<ul><li><p>Ibuprofen is un-ionized, therefore more absorbable, in the fasted (empty) stomach - however, its solubility is poor. </p></li><li><p> Aspirin is un-ionized in the stomach and is more soluble so is absorbed there. </p></li><li><p> Many drugs are absorbed well in the stomach, but the adaptations of the small intestine mean most absorption occurs there.</p></li></ul><p></p>
New cards
19

what is an alternative way to measure lipophilicity?

  • LogP only takes into account the partitioning of neutral, un-ionized species.

  • The distribution coefficient, D (expressed as LogD), can give a more realistic measure of lipophilicity by taking charged species into account.

  • Like LogP, the higher the value of LogD, the more lipophilic the drug is.

  • LogD can change considerably depending on where in the GI tract a drug is, e.g. the weakly basic drug warfarin (right).

<ul><li><p>LogP only takes into account the partitioning of neutral, un-ionized species. </p></li><li><p> The distribution coefficient, D (expressed as LogD), can give a more realistic measure of lipophilicity by taking charged species into account. </p></li><li><p>Like LogP, the higher the value of LogD, the more lipophilic the drug is. </p></li><li><p> LogD can change considerably depending on where in the GI tract a drug is, e.g. the weakly basic drug warfarin (right).</p></li></ul><p></p>
New cards
20
term image
New cards
21

how does hydrogen bonding affect lipophilicity?

  • it needs to lose water when passing into the membrane

  • the more H bonding, the more hydrophilic so the poorer the absorption

  • De-solvation must occur, i.e. hydrogen bonds must be broken, before a drug in solution can enter the lipid plasma membrane.

<ul><li><p>it needs to lose water when passing into the membrane </p></li><li><p>the more H bonding, the more hydrophilic so the poorer the absorption </p></li><li><p>De-solvation must occur, i.e. hydrogen bonds must be broken, before a drug in solution can enter the lipid plasma membrane.</p></li></ul><p></p>
New cards
22
term image
New cards
23

what drug properties does lipinskis rule of five investigate?

  • Lipophilicity

  • LogP

  • Size

  • MW

  • Hydrogen bonding

  • number of donors and acceptors

New cards
24

The Ro5 predicts that poor oral absorption is likely if two or more of following criteria are broken:

  • The MW is ≤ 500

  • The Log P is ≤ 5

  • The number of H-bond donors (sum of OH + NH) ≤ 5

  • There number H-bond acceptors (sum of N + O) ≤ 10

  • all of the following are divisible by 5, hence the rule of 5

<ul><li><p>The MW is ≤ 500 </p></li><li><p> The Log P is ≤ 5 </p></li><li><p> The number of H-bond donors (sum of OH + NH) ≤ 5 </p></li><li><p> There number H-bond acceptors (sum of N + O) ≤ 10 </p></li><li><p>all of the following are divisible by 5, hence the rule of 5</p></li></ul><p></p>
New cards
25

what are the exceptions to the rule?

  • Some drugs break the Ro5 but are still absorbed at acceptable levels.

  • Most of the drugs which do not comply with the Ro5 are antibiotics

  • natural compounds or semi-synthetic.

  • Vitamins, cardiac glycosides and antifungals tend to break the Ro5 too.

  • Natural products generally adhere to the LogP and H-bond donor requirements.

  • If oral bioavailability is poor, modified formulations or alternative routes may be used.

New cards
26

examples of the Ro5 being tested:

knowt flashcard image
New cards
27

what is lipinskis rule of 5 useful to asses?

  • Lipinski's Rule of Five is very useful for assessing the likelihood of a drug being well absorbed following oral delivery.

New cards
28

However, there are alternative approaches and "rules" which can be used in combination with (or instead of) the Ro5. For example, Veber's Rules

New cards
29

what are vebers rules?

  • Number of rotatable bonds ≤ 10

  • Total polar surface area (TPSA) ≤ 140 Å2 or total H-bond count ≤ 12.

  • the lower the better for both

  • the bigger the molecule, the more the rotatable bonds and the higher polar SA.

<ul><li><p>Number of rotatable bonds ≤ 10</p></li><li><p>Total polar surface area (TPSA) ≤ 140 Å2 or total H-bond count ≤ 12. </p></li><li><p>the lower the better for both </p></li><li><p> the bigger the molecule, the more the rotatable bonds and the higher polar SA.</p></li></ul><p></p><p></p>
New cards
30

optimising drug properties for oral absorption: what if a drug which has excellent activity in vitro has poor bioavailability?

  • It may be possible to make chemical modifications to alter polarity or LogP assuming this doesn't affect binding to its target.

    This can include:

  • Incorporation of ionizable groups to increase solubility.

  • Changing the pKa functional groups to increase lipophilicity.

  • Reducing the number of hydrogen bond donors or acceptors.(changing functional groups)

  • Pro-drug strategies.

New cards
31

If a drug is too hydrophilic, oral absorption will be limited due to limited permeability. how can you improve its lipophilicity and membrane permeability?

  • drugs can be chemically modified with lipophilic groups (or groups which target transporters).

  • Following absorption, metabolic processes within cells cleave the lipophilic groups to release the active drug.

  • This is known as the pro-drug approach, and many common medicines contain pro-drugs rather than the true API.

<ul><li><p>drugs can be chemically modified with lipophilic groups (or groups which target transporters).</p></li><li><p> Following absorption, metabolic processes within cells cleave the lipophilic groups to release the active drug. </p></li><li><p>This is known as the pro-drug approach, and many common medicines contain pro-drugs rather than the true API.</p></li></ul><p></p>
New cards
32

summary:

read

<p>read</p>
New cards

Explore top notes

note Note
studied byStudied by 1 person
808 days ago
5.0(1)
note Note
studied byStudied by 16 people
847 days ago
5.0(1)
note Note
studied byStudied by 30 people
704 days ago
5.0(1)
note Note
studied byStudied by 54 people
185 days ago
5.0(1)
note Note
studied byStudied by 181 people
919 days ago
5.0(2)
note Note
studied byStudied by 35 people
243 days ago
5.0(1)
note Note
studied byStudied by 3 people
51 days ago
5.0(1)
note Note
studied byStudied by 21 people
612 days ago
5.0(1)

Explore top flashcards

flashcards Flashcard (59)
studied byStudied by 3 people
147 days ago
5.0(1)
flashcards Flashcard (35)
studied byStudied by 10 people
549 days ago
5.0(1)
flashcards Flashcard (415)
studied byStudied by 6 people
631 days ago
4.0(2)
flashcards Flashcard (30)
studied byStudied by 5 people
701 days ago
5.0(1)
flashcards Flashcard (104)
studied byStudied by 117 people
371 days ago
5.0(1)
flashcards Flashcard (30)
studied byStudied by 29 people
423 days ago
5.0(2)
flashcards Flashcard (57)
studied byStudied by 17 people
707 days ago
5.0(1)
flashcards Flashcard (40)
studied byStudied by 35 people
57 minutes ago
5.0(1)
robot